CONTOUR^®NEXT ONE

^*Before use please see the CONTOUR^®NEXT ONE user guide for full instructions

^**On a compatible Android or iOS operating system. For a list of compatible operating systems, please visit compatibility.contourone.com

^***95% of the measured glucose values needed to fall within either ±0.83 mmol/L (±15 mg/dL) of the average measured values of the reference measurement procedure at glucose concentrations <5.55 mmol/L (<100 mg/dL) or within ±15% at glucose concentrations ≥5.55 mmol/L (≥100 mg/dL). 99% of individual glucose measured values need to fall within zones A and B of the Consensus Error Grid (CEG) for type 1 diabetes.³

^‡In a clinical study, conducted in accordance with the requirements of ISO 15197:2013, the CONTOUR^®NEXT ONE not only met and exceeded the minimum requirements of the standard but an ad hoc analysis determined where 95% of results fell during the study, which was within ±0.47 mmol/L or ±8.4% of the laboratory reference value for glucose concentrations <5.55 mmol/L or ≥5.55 mmol/L, respectively, when tested via subject obtained capillary fingertip results (patients with diabetes)

1. CONTOUR^®NEXT ONE BGMS User Guide Rev 08/19.
2. Christiansen M et al. J Diabetes Sci Technol 2017;11(3):567-573
3. International Organization for Standardization. In vitro diagnostic test systems - requirements for blood-glucose monitoring systems for self-testing in managing diabetes mellitus (ISO 15197). International Organization for Standardization, Geneva, Switzerland, 2013.
4. Richardson JM et al. Clinical Relevance of Reapplication of Blood Samples During Blood Glucose Testing. Poster presented at the 20th Annual Diabetes Technology Meeting (DTM); November 12-14, 2020.